Korro Bio (KRRO) vs Voyager Therapeutics (VYGR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Voyager Therapeutics (VYGR) has outperformed Korro Bio (KRRO) over the past year, losing 47.8% versus a loss of 78.5%. Over five years, VYGR leads with a -39.8% price change compared with -97.0% for KRRO. Korro Bio is the larger company by market cap ($154.5 million vs $152.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KRRO | VYGR |
|---|---|---|
| Share price | $10.49 | $2.47 |
| Market cap | $154.47M | $152.20M |
| 1-day change | +7.48% | +0.41% |
| YTD return | +30.96% | -37.15% |
| 1-year return | -78.49% | -47.78% |
| 5-year return | -97.05% | -39.76% |
| EPS (TTM) | $-9.88 | $-1.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $55.89 | $5.55 |
| 52-week low | $5.20 | $2.39 |
| Distance from 52-week high | -81.23% | -55.50% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +92.56% | +502.83% |
| Average volume | 148.67K | 563.34K |
| Shares outstanding | 14.73M | 61.62M |
| Employees | 57 | 141 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- VYGR has outperformed KRRO by 30.7 percentage points over the past year.
About Korro Bio
KRRO stock →Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia.
Healthcare · Biotechnology · 57 employees
About Voyager Therapeutics
VYGR stock →Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease.
Healthcare · Biotechnology · 141 employees
KRRO vs VYGR FAQ
Which is bigger, Korro Bio or Voyager Therapeutics?
Korro Bio (KRRO) is larger, with a market capitalization of $154.47M compared with $152.20M for Voyager Therapeutics (VYGR).
Which stock has performed better over the past year, KRRO or VYGR?
VYGR returned -47.78% over the past 12 months, compared with -78.49% for KRRO (price return, excluding dividends). Past performance does not predict future results.
Are Korro Bio and Voyager Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.